Latest Period
Q1 2026
Security Snapshot
DEXCOM INC - Common Stock (DXCM) Institutional Ownership
CUSIP: 252131107
13F Institutional Holders and Ownership History from Q1 2014 to Q2 2026
Institutions Reporting
951
Shares (Excl. Options)
363,066,157
Price
$62.80
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Security type / class
- Equity / Common Stock
- Symbol
- DXCM on Nasdaq
- All holders as of 31 Mar 2026
- Q1 2026
- Total 13F shares
- 363,066,157
- Total 13F value
- $22,831,429,957
- Portfolio coverage rank
- 0.01%
- Share change
- +3,006,977
- Value change
- +$152,342,125
- Number of holders
- 951
- Shares outstanding
- 385,156,449
- SEC-reported price per share
- $67.35
- Insider filing price
- $67.35
Latest holder snapshot
5 signals
Issuer context
Names, identifiers, and filing context for this profile.
3 identity fields
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Key facts
- DXCM - DEXCOM INC - Common Stock is tracked under CUSIP 252131107.
- 951 institutions reported positions in Q1 2026.
- 3 significant owners is listed from Schedule 13D/13G reporting.
Change
- Holder count moved from 951 to 28 between Q1 2026 and Q2 2026.
- SEC-reported value moved from $22,831,429,957 to $106,467,393.
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Form 13F
Open SEC evidence
Latest holder context comes from 951 institutions filings for Q1 2026.
Security key
252131107
Latest holder period
Q1 2026
13F holders
951
13D/G owners
3
CIK / CUSIP context first
Open Q1 2026 holders
DXCM full holder history
DEXCOM INC SEC filings
DEXCOM INC company facts
DEXCOM INC insider transactions
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 252131107:
13D/G owners
Significant owners
Large-stake holder rows connected to Schedule 13D/G evidence.
Rows
3
Security
DXCM
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| BlackRock, Inc. | 8.3% | $2,317,545,182 | 32,504,140 | BlackRock, Inc. | 31 Mar 2025 | |||
| VANGUARD CAPITAL MANAGEMENT LLC | 7.5% | $1,811,668,090 | 28,848,218 | Vanguard Capital Management | 31 Mar 2026 | |||
| VANGUARD PORTFOLIO MANAGEMENT LLC | 5% | $1,213,457,145 | 19,322,566 | Vanguard Portfolio Management | 31 Mar 2026 |
As of 31 Mar 2026, 951 institutional investors reported holding 363,066,157 shares of DEXCOM INC - Common Stock (DXCM). This represents 94% of the company’s total 385,156,449 outstanding shares.
13F concentration
Top 25 institutional shareholders
Largest 13F positions for this security by reported shares and value.
Top holder share
58%
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| BlackRock, Inc. | 10% | 38,964,371 | -2.2% | 0.04% | $2,446,962,501 |
| VANGUARD CAPITAL MANAGEMENT LLC | 6.5% | 25,020,961 | 0% | 0.04% | $1,571,316,351 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 5% | 19,219,953 | 0% | 0.06% | $1,207,013,048 |
| STATE STREET CORP | 4.7% | 17,934,847 | -0.88% | 0.04% | $1,126,308,392 |
| BAILLIE GIFFORD & CO | 4.1% | 15,599,525 | +0.3% | 1% | $979,650,170 |
| ALLIANCEBERNSTEIN L.P. | 3.4% | 12,923,644 | +50% | 0.28% | $857,742,252 |
| GEODE CAPITAL MANAGEMENT, LLC | 3.2% | 12,346,638 | +12% | 0.05% | $772,908,692 |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | 2.5% | 9,746,174 | +22% | 0.13% | $612,059,728 |
| WELLINGTON MANAGEMENT GROUP LLP | 2.4% | 9,326,240 | +203% | 0.11% | $585,687,871 |
| Amundi | 1.6% | 6,332,561 | +29% | 0.11% | $397,684,831 |
| JPMORGAN CHASE & CO | 1.6% | 5,999,470 | -3.5% | 0.03% | $371,367,210 |
| Invesco Ltd. | 1.5% | 5,594,860 | +5.3% | 0.05% | $351,357,215 |
| MORGAN STANLEY | 1.3% | 5,042,044 | -0.6% | 0.02% | $316,640,468 |
| UBS Group AG | 1.1% | 4,349,959 | +126% | 0.05% | $273,177,426 |
| AMERIPRISE FINANCIAL INC | 1.1% | 4,240,784 | +99% | 0.06% | $266,322,554 |
| CIBC Bancorp USA Inc. | 1.1% | 4,217,134 | +6060% | 0.36% | $264,690,542 |
| NORTHERN TRUST CORP | 0.89% | 3,425,025 | +1.4% | 0.03% | $215,091,570 |
| DEUTSCHE BANK AG\ | 0.88% | 3,392,733 | -22% | 0.07% | $213,063,633 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 0.82% | 3,175,299 | +3.1% | 0.03% | $199,408,777 |
| GOLDMAN SACHS GROUP INC | 0.79% | 3,043,635 | +25% | 0.03% | $191,140,301 |
| AMERICAN CENTURY COMPANIES INC | 0.76% | 2,945,010 | +32% | 0.1% | $184,946,628 |
| BANK OF AMERICA CORP /DE/ | 0.76% | 2,933,726 | -23% | 0.01% | $184,237,986 |
| RAYMOND JAMES FINANCIAL INC | 0.72% | 2,782,627 | +13% | 0.05% | $173,948,909 |
| JANUS HENDERSON GROUP PLC | 0.69% | 2,644,539 | +32% | 0.08% | $166,077,317 |
| Legal & General Group Plc | 0.68% | 2,609,354 | +0.16% | 0.04% | $163,867,432 |
Quarter history
Institutional holders across reporting periods
Holder count, reported shares/value, and median price by quarter.
Periods
50
Latest
Q1 2026
Rows shown
1-25 of 50
| Period | 13F Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q2 | 1,580,221 | $106,467,393 | -$65,635,582 | $67.35 | 28 |
| 2026 Q1 | 363,066,157 | $22,831,429,957 | +$152,342,125 | $62.80 | 951 |
| 2025 Q4 | 363,861,384 | $24,153,964,944 | +$68,795,707 | $66.37 | 916 |
| 2025 Q3 | 364,345,068 | $24,504,981,239 | -$446,475,167 | $67.29 | 898 |
| 2025 Q2 | 363,717,079 | $31,720,153,850 | +$620,498,372 | $87.29 | 929 |
| 2025 Q1 | 357,522,884 | $24,367,959,079 | -$21,830,100 | $68.29 | 918 |
| 2024 Q4 | 356,520,250 | $27,741,592,016 | -$279,743,784 | $77.77 | 940 |
| 2024 Q3 | 357,200,222 | $23,960,310,643 | -$1,530,910,004 | $67.04 | 871 |
| 2024 Q2 | 373,073,419 | $42,285,500,029 | +$662,526,670 | $113.38 | 980 |
| 2024 Q1 | 367,433,762 | $50,918,835,024 | -$893,108,760 | $138.70 | 1,023 |
| 2023 Q4 | 376,420,513 | $46,714,761,535 | +$1,256,458,516 | $124.09 | 963 |
| 2023 Q3 | 367,596,728 | $34,254,428,099 | -$325,172,905 | $93.30 | 890 |
| 2023 Q2 | 368,588,625 | $47,303,203,662 | -$86,323,559 | $128.51 | 940 |
| 2023 Q1 | 369,281,709 | $42,884,123,591 | +$52,677,258 | $116.18 | 891 |
| 2022 Q4 | 373,099,760 | $42,233,817,121 | +$225,153,200 | $113.24 | 901 |
| 2022 Q3 | 371,208,363 | $29,922,677,791 | -$111,395,992 | $80.54 | 760 |
| 2022 Q2 | 370,318,253 | $27,605,947,295 | +$20,054,274,905 | $74.53 | 772 |
| 2022 Q1 | 94,624,602 | $48,293,370,260 | +$1,138,375,535 | $511.60 | 843 |
| 2021 Q4 | 92,168,299 | $49,456,533,397 | -$1,108,963,197 | $536.95 | 906 |
| 2021 Q3 | 93,700,793 | $51,237,135,830 | -$502,542,871 | $546.86 | 784 |
| 2021 Q2 | 94,700,933 | $40,431,864,257 | +$1,510,178,055 | $427.00 | 716 |
| 2021 Q1 | 92,085,325 | $33,095,119,084 | +$509,060,434 | $359.39 | 716 |
| 2020 Q4 | 90,898,678 | $33,599,827,733 | -$501,643,933 | $369.72 | 716 |
| 2020 Q3 | 91,873,135 | $37,818,156,552 | -$149,409,008 | $412.23 | 717 |
| 2020 Q2 | 92,133,123 | $37,347,784,993 | +$419,792,629 | $405.40 | 709 |